BELKYRA™ is a prescription medicine and is the only FDA-approved injectable treatment used in adults to improve the appearance and profile of moderate to severe fat below the chin (submental fat), also called “double chin.” It is not known if BELKYRA™ is safe and effective for use outside of the submental area or in children less than 18 years of age.
Belkyra™ is the first Health Canada-approved injectable for reducing “sub-mental fullness” – otherwise known as a double chin. This type of under-chin fat may be causing you to feel self-conscious, unattractive or otherwise dissatisfied with your appearance. Whether the fullness is a result of genetics, weight fluctuations or aging, Belkyra is an effective way to reduce it.
Belkyra is a synthetic version of a naturally occurring molecule. Deoxycholic acid exists naturally in your body. The molecule breaks down dietary fat. Belkyra uses synthetic deoxycholic acid to destroy fat cells under your chin.
Once the fat cells have been destroyed, they can no longer store or regain fat, so most people do not need further treatment once the desired results are reached. The effect will be permanent, unless new fat cells are gained.
Most people require more than one injection appointment to reach the desired effect. Your treatment plan will depend on the nature and extent of your sub-mental fullness. Multiple, tiny injections will be administered at each appointment. Most people see results after two appointments, but may require up to six such appointments. Each session is spaced a month apart from any other sessions.
The active ingredient in BELKYRA™ is synthetic deoxycholic acid. Deoxycholic acid is a naturally occurring molecule in the body that aids in the breakdown and absorption of dietary fat. When injected into the fat beneath the chin, BELKYRA™ destroys fat cells, and once destroyed, these cells can no longer store or accumulate fat. This results in a noticeable reduction in fullness under the chin, revealing an improved chin profile.
Your specialist will create a tailored treatment plan based on your chin profile. At each treatment, you will be given multiple small injections under your chin. You may receive up to 6 treatment sessions, spaced at least 1 month apart. Many patients experience visible results in 2 to 4 BELKYRA™ treatments. 59% of patients received 6 treatments in clinical studies.
BELKYRA™ can cause serious side effects, including trouble swallowing and nerve injury in the jaw that can temporarily cause an uneven smile or facial muscle weakness. In clinical studies, nerve injury in the jaw resolved on its own in a median of 44 days (range of 1 to 298 days), and trouble swallowing resolved on its own in a median of 3 days (range of 1 to 81 days).
The most common side effects are swelling, bruising, pain, numbness, redness and areas of hardness around the treatment area. These are not all of the possible side effects of BELKYRA™. Call your healthcare provider for medical advice about side effects.
When injected into fat under the chin, BELKYRA™ causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat. After reaching your desired aesthetic, further treatment is not expected.
BELKYRA™ has been the focus of a global clinical development program involving over 20 clinical studies. More than 1600 people were treated with BELKYRA™ in these studies.
Only you and your doctor can decide if BELKYRA™ is right for you. If you’re bothered by fullness under your chin and wish to avoid surgery, ask your doctor about BELKYRA™.